Ingredient
N-Hydroxysuccinimide
N-Hydroxysuccinimide is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is absorbed into the body.
- NHS
- HOSu
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Last checked
- 15 September 2026
- The day this assessment was read from the catalogue
N-Hydroxysuccinimide and pregnancy
Caution Advised
- Absorbed into the body
N-Hydroxysuccinimide is a chemical compound used in cosmetic formulations for skin brightening, typically targeting hyperpigmentation. It works by interfering with melanin production pathways, though its exact mechanism in topical applications is still being studied. There are no published studies examining the safety of topical N-Hydroxysuccinimide during pregnancy. As a small molecule with unknown absorption characteristics, there is theoretical concern about systemic absorption through the skin. Without data on placental transfer or fetal effects, it's impossible to rule out risks to developing fetuses. Given the complete absence of pregnancy safety data and the ingredient's chemical reactivity, many dermatologists recommend avoiding novel brightening agents during pregnancy in favor of well-studied alternatives. The conservative approach is to postpone use of ingredients without established safety profiles until after delivery.
N-Hydroxysuccinimide and breastfeeding
Caution Advised
- Passes into breast milk
N-Hydroxysuccinimide is a brightening agent used topically for hyperpigmentation. As a relatively small chemical molecule, questions exist about whether it could be absorbed systemically and potentially transfer into breast milk. No studies have evaluated the presence of N-Hydroxysuccinimide in breast milk or its effects on breastfed infants. The lack of data on absorption rates, metabolism, and excretion makes it difficult to assess infant exposure risk. Most lactation consultants recommend avoiding cosmetic ingredients without established breastfeeding safety data. Until research establishes the safety profile for breastfeeding mothers, many healthcare providers suggest using well-studied alternatives for skin brightening. Women who choose to use products containing this ingredient should apply them to areas away from the breast to minimize any potential infant contact.
N-Hydroxysuccinimide and postpartum
Safe to Use
- Irritant
For postpartum women not breastfeeding, N-Hydroxysuccinimide can be used to address common concerns like melasma or post-inflammatory hyperpigmentation that often develops during pregnancy. The primary consideration is potential skin sensitivity, as postpartum skin may be more reactive. Without breastfeeding concerns, the main risk is topical irritation rather than systemic effects. Starting with lower concentrations and monitoring skin response is advisable. If irritation occurs, well-studied alternatives like niacinamide or vitamin C offer similar brightening benefits with more established safety profiles.
N-Hydroxysuccinimide and trying to conceive
Caution Advised
For women trying to conceive, the same precautionary approach applies as during pregnancy due to the lack of reproductive safety data for N-Hydroxysuccinimide. Since pregnancy may occur at any time during the TTC period, and the ingredient's effects during early conception and embryonic development are unknown, avoiding use is the conservative choice. Most fertility specialists recommend discontinuing cosmetic ingredients without established safety data once actively trying to conceive. Well-studied brightening alternatives like niacinamide, vitamin C, or azelaic acid provide similar benefits without theoretical reproductive concerns. This approach minimizes any potential risk during the critical early weeks of pregnancy when women may not yet know they've conceived.
N-Hydroxysuccinimide and PCOS
Safe to Use
N-Hydroxysuccinimide is a brightening agent that can help address post-inflammatory hyperpigmentation from acne, which is common in women with PCOS. There is no evidence suggesting it interferes with hormones or affects androgen levels. For PCOS-related skin concerns, this ingredient may help reduce dark spots left by hormonal acne breakouts. The chemical structure of N-Hydroxysuccinimide does not resemble hormones and has no known endocrine-disrupting properties. It can be incorporated into a PCOS skincare routine without hormonal concerns. Women with PCOS often have sensitive or inflamed skin due to hormonal fluctuations. If irritation occurs from N-Hydroxysuccinimide, gentler alternatives like niacinamide offer similar brightening benefits while also helping to regulate sebum production and reduce inflammation associated with PCOS.
N-Hydroxysuccinimide and general use
Safe to Use
- Irritant
N-Hydroxysuccinimide is an emerging ingredient in skin brightening formulations, typically used to reduce hyperpigmentation and even skin tone. It's often combined with other actives like peptides or other brightening agents to enhance effectiveness. For the general population not pregnant or breastfeeding, the primary concern is potential skin irritation rather than systemic health effects. Some users report sensitivity, particularly when first introducing the ingredient. As with any active ingredient, patch testing is recommended, and use should be discontinued if significant irritation develops. The ingredient lacks the extensive safety database of more established brightening agents, but no serious adverse effects have been widely reported in cosmetic use. For those concerned about using newer ingredients, well-studied alternatives like niacinamide, vitamin C, alpha arbutin, or azelaic acid offer proven brightening benefits with decades of safety data.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of N-Hydroxysuccinimide, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store